Chiropractors in Lafayette, NJ Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Dr. Mary Jean Negri, RN, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 23 Route 15, Lafayette, NJ 07848 Phone: 973-579-1608 Fax: 973-579-7408 |
 Vitality Health Center Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 82 State Route 15, Lafayette, NJ 07848 Phone: 973-383-5052 |
East Blackwell Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 23 Route 15, Lafayette, NJ 07848 Phone: 973-361-3500 Fax: 973-361-1360 |
Dr. Michele Takacs, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 82 State Route 15, Lafayette, NJ 07848 Phone: 973-383-5052 |
 Dr. Donald Thomas Alosio Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 45 Decker Rd, Lafayette, NJ 07848 Phone: 862-268-3500 Fax: 973-300-5640 |
News Archive
Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects
Opioids, such as morphine, are still the most effective class of painkillers, but they come with unwanted side effects and can also be addictive and deadly at high doses. Designing new pain-killing drugs of this type involves testing them on their corresponding receptors, but access to meaningful quantities of these receptors that can work in experimental conditions has always been a limiting factor.
Data shows potential health benefits of S-equol in relieving menopausal symptoms
The findings of a scientific conference examining the growing body of research and potential health benefits of S-equol were published this month in the Journal of Nutrition. Manuscripts based on presentations made at the conference, which was organized by the Life Sciences Research Office, reveal data that S-equol is a safe, natural and effective solution to providing relief of menopausal symptoms such as hot flashes and muscle discomfort.
TASE approves new listing of PROLOR Biotech's common stock
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
Cardiologists question FDA recommendations on genetic testing before taking Plavix
Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).
Study identifies gene that could decrease chances of developing alcoholic cirrhosis
Researchers at Indiana University School of Medicine are learning more about how a person's genes play a role in the possibility they'll suffer from alcoholic cirrhosis with the discovery of a gene that could make the disease less likely.
› Verified 5 days ago
Occupational Therapists
Physical Therapists
Speech-Language Pathologists
Chiropractors